Company Filing History:
Years Active: 2024-2025
Title: Innovations by Charles Evans in Pharmaceutical Compositions
Introduction
Charles Evans is an accomplished inventor based in West Sussex, GB. He has made significant contributions to the field of pharmaceutical compositions, particularly those involving cannabinoids. With a total of 2 patents to his name, Evans is recognized for his innovative approaches to oral delivery systems.
Latest Patents
Evans' latest patents focus on compositions and dosage forms for oral delivery. The disclosures provide pharmaceutical compositions that comprise a cannabinoid, along with dosage forms designed for oral delivery, such as sublingual or buccal methods. These compositions are noted for being substantially homogeneous and maintaining stability and monophasic characteristics upon storage. Furthermore, the methods outlined in these patents are aimed at pain management and treating various diseases and conditions, including dementia, sleep disorders, movement disorders, mental disorders, and multiple sclerosis.
Career Highlights
Throughout his career, Charles Evans has been associated with Rhodes Technologies, where he has furthered his research and development efforts in pharmaceutical innovations. His work has contributed to advancements in the delivery of cannabinoid-based therapies, showcasing his commitment to improving patient outcomes.
Collaborations
Evans has collaborated with notable colleagues, including Ping Chang and Marc Brown. These partnerships have likely enhanced the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Charles Evans stands out as a key figure in the development of cannabinoid-based pharmaceutical compositions. His patents reflect a dedication to advancing medical treatments and improving the quality of life for patients with various conditions.